Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Mar 12, 2009

Premium

Advanced Proteome Therapeutics said this week that Kenneth Phillippe has become the firm’s CFO.

Phillippe replaces Alexander Krantz who had served as CFO since October 2006. Krantz will remain president, CEO and secretary of APT.

Phillipe has served as CFO of Exchequer Resource and CFO and secretary of Bold Ventures. He also held positions as director and officer of Urodynamix Technologies; CFO of Columbia Goldfields; and secretary, treasurer, CFO, and principal accounting officer of Amazon Goldsands and Constitution Mining.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more